Agf Investments LLC Amgen Inc Transaction History

Agf Investments LLC

$1.09 Billion
Q3 2022

A detailed history of Agf Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Agf Investments LLC holds 7,286 shares of AMGN stock, worth $2.1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

7,286

Previous 3,821 90.68%

Holding current value

$2.1 Million

Previous $930,000 76.56%

% of portfolio

0.15%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $777,753 - $877,164	3,465 Added 90.68%	7,286 $1.64 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $744,501 - $828,499	3,227 Added 543.27%	3,821 $930,000
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $2,192 - $2,425	10 Added 1.71%	594 $144,000
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $97,451 - $111,524	-490 Reduced 45.62%	584 $131,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $217,364 - $254,668	-1,024 Reduced 48.81%	1,074 $228,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $605,906 - $672,209	-2,594 Reduced 55.29%	2,098 $511,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $315,556 - $367,729	-1,422 Reduced 23.26%	4,692 $1.17 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $442,280 - $526,677	-2,044 Reduced 25.06%	6,114 $1.41 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $1.09 Million - $1.22 Million	-4,659 Reduced 36.35%	8,158 $2.07 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $1.04 Million - $1.28 Million	5,266 Added 69.74%	12,817 $3.02 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $64,330 - $85,320	353 Added 4.9%	7,551 $1.53 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $71,710 - $92,172	-379 Reduced 5.0%	7,198 $1.74 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $361,974 - $433,720	-2,079 Reduced 21.53%	7,577 $1.47 Million
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $48,009 - $56,278	288 Added 3.07%	9,656 $1.78 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $4.2 Million - $4.74 Million	-23,230 Reduced 71.26%	9,368 $1.78 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $979,951 - $1.14 Million	-5,493 Reduced 14.42%	32,598 $6.35 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $4.44 Million - $5 Million	23,959 Added 169.54%	38,091 $7.9 Million
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $79,118 - $89,196	-427 Reduced 2.93%	14,132 $2.93 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $1.82 Million - $2.04 Million	10,957 Added 304.19%	14,559 $2.69 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $610,286 - $713,196	3,602 New	3,602 $614,000
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $5,401 - $6,034	-32 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $5,353 - $6,112	32	32 $6,000

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.

Account

Agf Investments LLC Amgen Inc Transaction History